333 results on '"Caraceni, T"'
Search Results
2. Treatment of Motor Fluctuations in Parkinson’s Disease: Controlled Release Preparations
3. Adrenal Medulla Autograft in Caudate Nucleus as Treatment for Parkinson Disease
4. Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients
5. Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis?
6. Survival in multiple system atrophy: a study of prognostic factors in 59 cases
7. Progression of motor and cognitive impairment in Parkinson's disease
8. Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients
9. Spasmodic dystonic laterocollis in familial cerebellar ataxia
10. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group
11. A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of 1-dopa, 1-deprenyl and dopaminoagonists. Study design and short term results
12. Book reviews
13. The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-β-carbomethoxy-3-β-(4-fluorophenyl)-tropane in patients with movement disorders
14. Cognitive Dysfunction and Impaired Organization of Complex Motility in Degenerative Parkinsonian Syndromes
15. Adrenal Medulla Autograft in Caudate Nucleus as Treatment for Parkinson Disease
16. Hemichorea due to a cavernous angioma of the caudate. Case report of an aged patient
17. Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study
18. Neuroendocrine Control of Pituitary Function in Extrapiramidal Disorders
19. Failure of MIF-I to affect behavioral responses in patients with parkinson's disease under l-dopa therapy
20. Madopar HBS and the decompensated phase of Parkinson disease
21. Deprenyl in Parkinson disease: personal experience
22. The cerebrospinal fluid choline levels in patients with Huntington's chorea: Negative effect of haloperidol treatment
23. Book reviews
24. Idiopathic dystonia: Neuropharmacological study
25. Effects of DA agonist in Huntington disease hyperkinesia
26. Neuroendocrine effects of quipazine in man in health state or with neurological disorders
27. Familial syringomyelia: A report of four cases
28. Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis
29. Book reviews
30. 22. Effect of L-5HTP and Drugs Acting on Serotonin Metabolism in Various Myoclonic Syndromes
31. SURVIVAL IN SENILE AND PRESENILE ALZHEIMERS-DISEASE
32. Dosage scheme for use of levodopa in Parkinson's disease [Schema posologico per l'utilizzo della levodopa nella malattia di Parkinson]
33. Long-term ventralis intermedius thalamic stimulation for parkinsonian tremor. Italian Registry for Neuromodulation in Movement Disorders
34. An Italian multicentre randomized study on early treatment of Parkinson disease: Comparison of L-dopa, L-deprenyl and dopamine-agonists. Study design and preliminary results
35. The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders
36. Variation of therapeutic response in Parkinson's disease: a retrospective study
37. Growth hormone responses to cholinergically active drugs in patients with dementia of the Alzheimer type
38. Variation of therapeutic response in Parkinson's disease: a retrospective study
39. Bromocriptine — lisuride cross tolerance
40. Book reviews
41. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study
42. Spasmodic dystonic laterocollis in familial cerebellar ataxia.
43. Psychopathological aspects of huntington's disease and correlations with motor and cognitive impairment: A study of patients and relatives
44. Variations in Axial, Proximal, and Distal Motor Response to L-Dopa in Multisystem Atrophy and Parkinsonʼs Disease
45. MRI in sporadic olivopontocerebellar atrophy and striatonigral degeneration
46. Psychiatric Symptoms Do Not Correlate With Cognitive Decline, Motor Symptoms, or CAG Repeat Length in Huntington's Disease
47. Multiple System Atrophy
48. A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease
49. Dopamine agonists in the treatment of Parkinson's Disease
50. Loss of osmotic thirst in multiple system atrophy: association with sinoaortic baroreceptor deafferentation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.